Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The debt to assets ratio is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.00%
DEBT TO ASSETS RATIO AVG 3Y
0.00%
DEBT TO ASSETS RATIO AVG 5Y
0.00%
DEBT TO ASSETS RATIO AVG 10Y
0.00%
DEBT TO ASSETS RATIO AVG 15Y
0.03%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.13%
median of 390 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Atossa Therapeutics, Inc.
Market Cap
$24.44M
Debt to Assets Ratio
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$25.48M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$21.90M
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$20.93M
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.77M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$30.92M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atossa Therapeutics, Inc. (ATOS) | $24.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | 0.09% | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | 0.17% | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | 0.08% | N/A | N/A | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | 0.16% | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $18.82M | 0.26% | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | 0.00% | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $30.65M | 0.00% | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | 0.01% | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | 0.19% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
5.69
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.01% |
| 2020-12-31 | 0.04% |
| 2020-09-30 | 0.27% |
| 2020-06-30 | 0.43% |
| 2020-03-31 | 0.32% |
| 2019-12-31 | 0.35% |
| 2019-09-30 | 0.47% |
| 2019-06-30 | 0.41% |
| 2019-03-31 | 0.60% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.51% |
| 2015-03-31 | 0.76% |
| 2014-12-31 | 1.06% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.13% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 4.39% |
| 2012-06-30 | 29.66% |
| 2012-03-31 | 18.30% |
| 2011-12-31 | 32.72% |
| 2011-09-30 | 24.42% |
| 2010-12-31 | 1259.16% |
| 2010-09-30 | 331.75% |
| 2010-06-30 | 12.14% |
